Market Closed -
Hong Kong S.E.
04:08:20 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
21.55
HKD
|
-0.92%
|
|
+8.40%
|
+5.38%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
75,452
|
49,504
|
43,125
|
54,681
|
58,004
|
62,251
|
-
|
-
|
Enterprise Value (EV)
1 |
91,399
|
63,204
|
63,166
|
64,207
|
58,004
|
65,785
|
53,111
|
61,814
|
P/E ratio
|
12.1
x
|
6.87
x
|
5.55
x
|
6.42
x
|
6.41
x
|
6.34
x
|
5.79
x
|
5.26
x
|
Yield
|
2.36%
|
4.35%
|
5.43%
|
4.68%
|
-
|
4.81%
|
5.26%
|
5.73%
|
Capitalization / Revenue
|
0.18
x
|
0.11
x
|
0.08
x
|
0.1
x
|
0.1
x
|
0.1
x
|
0.09
x
|
0.08
x
|
EV / Revenue
|
0.21
x
|
0.14
x
|
0.12
x
|
0.12
x
|
0.1
x
|
0.1
x
|
0.07
x
|
0.08
x
|
EV / EBITDA
|
5.09
x
|
3.21
x
|
2.67
x
|
2.59
x
|
2.35
x
|
2.47
x
|
1.83
x
|
1.95
x
|
EV / FCF
|
6.57
x
|
-13.8
x
|
9.72
x
|
3.47
x
|
-
|
5.74
x
|
5.54
x
|
4.77
x
|
FCF Yield
|
15.2%
|
-7.24%
|
10.3%
|
28.8%
|
-
|
17.4%
|
18.1%
|
21%
|
Price to Book
|
1.59
x
|
0.88
x
|
0.7
x
|
0.8
x
|
-
|
0.75
x
|
0.67
x
|
0.6
x
|
Nbr of stocks (in thousands)
|
2,967,629
|
3,118,654
|
3,120,656
|
3,120,656
|
3,120,656
|
3,120,656
|
-
|
-
|
Reference price
2 |
25.42
|
15.87
|
13.82
|
17.52
|
18.59
|
19.95
|
19.95
|
19.95
|
Announcement Date
|
3/30/20
|
3/21/21
|
3/20/22
|
3/26/23
|
3/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
425,273
|
456,415
|
521,051
|
552,148
|
596,570
|
651,835
|
710,621
|
773,759
|
EBITDA
1 |
17,950
|
19,667
|
23,634
|
24,769
|
24,639
|
26,669
|
29,072
|
31,711
|
EBIT
1 |
16,137
|
17,760
|
19,712
|
20,604
|
20,209
|
23,514
|
25,741
|
28,318
|
Operating Margin
|
3.79%
|
3.89%
|
3.78%
|
3.73%
|
3.39%
|
3.61%
|
3.62%
|
3.66%
|
Earnings before Tax (EBT)
1 |
13,760
|
15,598
|
17,003
|
18,564
|
19,512
|
21,350
|
23,390
|
25,730
|
Net income
1 |
6,253
|
7,187
|
7,759
|
8,526
|
9,054
|
9,827
|
10,774
|
11,894
|
Net margin
|
1.47%
|
1.57%
|
1.49%
|
1.54%
|
1.52%
|
1.51%
|
1.52%
|
1.54%
|
EPS
2 |
2.100
|
2.310
|
2.490
|
2.730
|
2.900
|
3.145
|
3.445
|
3.790
|
Free Cash Flow
1 |
13,909
|
-4,574
|
6,501
|
18,481
|
-
|
11,465
|
9,594
|
12,961
|
FCF margin
|
3.27%
|
-1%
|
1.25%
|
3.35%
|
-
|
1.76%
|
1.35%
|
1.68%
|
FCF Conversion (EBITDA)
|
77.49%
|
-
|
27.51%
|
74.61%
|
-
|
42.99%
|
33%
|
40.87%
|
FCF Conversion (Net income)
|
222.46%
|
-
|
83.79%
|
216.77%
|
-
|
116.67%
|
89.05%
|
108.97%
|
Dividend per Share
2 |
0.6000
|
0.6900
|
0.7500
|
0.8200
|
-
|
0.9592
|
1.049
|
1.144
|
Announcement Date
|
3/30/20
|
3/21/21
|
3/20/22
|
3/26/23
|
3/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 S1
|
---|
Net sales
1 |
223,608
|
203,765
|
252,650
|
249,120
|
271,931
|
261,472
|
290,676
|
18,687
|
155,433
|
300,950
|
144,969
|
150,650
|
295,619
|
321,924
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
-
|
8,772
|
10,940
|
9,057
|
11,547
|
-
|
5,895
|
10,869
|
5,937
|
4,691
|
10,628
|
11,691
|
Operating Margin
|
-
|
-
|
-
|
3.52%
|
4.02%
|
3.46%
|
3.97%
|
-
|
3.79%
|
3.61%
|
4.1%
|
3.11%
|
3.6%
|
3.63%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
5,228
|
8,866
|
4,161
|
6,485
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
362.2
|
2,514
|
4,104
|
1,752
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1.94%
|
1.62%
|
1.36%
|
1.21%
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/30/20
|
8/23/20
|
3/21/21
|
8/22/21
|
3/20/22
|
8/29/22
|
3/26/23
|
4/17/23
|
8/27/23
|
8/27/23
|
10/30/23
|
3/24/24
|
3/24/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
15,947
|
13,699
|
20,041
|
9,526
|
-
|
3,534
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
9,140
|
438
|
Leverage (Debt/EBITDA)
|
0.8884
x
|
0.6966
x
|
0.848
x
|
0.3846
x
|
-
|
0.1325
x
|
-
|
-
|
Free Cash Flow
1 |
13,909
|
-4,574
|
6,501
|
18,481
|
-
|
11,465
|
9,594
|
12,961
|
ROE (net income / shareholders' equity)
|
13.9%
|
13.9%
|
13.1%
|
13.1%
|
-
|
12%
|
12%
|
11.6%
|
ROA (Net income/ Total Assets)
|
2.47%
|
2.47%
|
2.4%
|
2.44%
|
-
|
2.45%
|
2.49%
|
2.49%
|
Assets
1 |
252,832
|
290,559
|
323,331
|
350,101
|
-
|
401,329
|
433,198
|
477,351
|
Book Value Per Share
2 |
16.00
|
18.10
|
19.80
|
21.80
|
-
|
26.70
|
29.70
|
33.20
|
Cash Flow per Share
2 |
6.320
|
3.590
|
2.980
|
6.720
|
-
|
6.040
|
3.430
|
6.080
|
Capex
1 |
4,868
|
4,585
|
2,807
|
2,482
|
-
|
3,328
|
3,173
|
3,309
|
Capex / Sales
|
1.14%
|
1%
|
0.54%
|
0.45%
|
-
|
0.51%
|
0.45%
|
0.43%
|
Announcement Date
|
3/30/20
|
3/21/21
|
3/20/22
|
3/26/23
|
3/24/24
|
-
|
-
|
-
|
Last Close Price
19.95
CNY Average target price
25.06
CNY Spread / Average Target +25.63% Consensus |
1st Jan change
|
Capi.
|
---|
| +5.38% | 8.59B | | +17.35% | 71.39B | | +2.39% | 25.1B | | +6.69% | 8.19B | | -20.96% | 7.91B | | +0.49% | 4.54B | | +17.12% | 4.31B | | -3.38% | 3.93B | | -2.61% | 3.86B | | +22.08% | 3.64B |
Pharmaceuticals Wholesale
|